Development of a bifunctional nanobiosensor for screening and detection of chemokine ligand in colorectal cancer cell line

被引:52
作者
Chung, Saeromi [1 ,2 ]
Chandra, Pranjal [3 ]
Koo, Jaseok Peter [4 ]
Shim, Yoon-Bo [1 ,2 ]
机构
[1] Pusan Natl Univ, Dept Chem, Busan 609735, South Korea
[2] Pusan Natl Univ, IBST, Busan 609735, South Korea
[3] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati 781039, Assam, India
[4] Yale Sch Med, Yale Canc Ctr, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA
基金
新加坡国家研究基金会;
关键词
Human Health; Bifunctional nanobiosensor; Chemokine; Cancer; Colorectal cancer cells; In vitro diagnosis; Human serum; CONDUCTING POLYMER; CXCL5; HEMOGLOBIN; EXPRESSION; MIGRATION; MARKER; SENSOR; MODEL; DRUG;
D O I
10.1016/j.bios.2017.09.031
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Highly sensitive detection of chemokines in various biological matrices and its interaction with a natural receptor molecule has tremendous importance in cell signaling, medical diagnostics, and therapeutics. In this direction, we have designed the first bifunctional nanobiosensor for chemokine screening and detection in a single experimental setting. The sensor probe was fabricated by immobilizing CXCR2 on the gold nanoparticles (AuNPs) deposited 2,2':5',2 ''-terthiophene-3' (p-benzoic acid) (TBA) nanocomposite film. The interaction between CXCR2 and chemokines was studied using electrochemical impedance spectroscopy (EIS) and voltammetry. CXCL5 among three ligands showed the strongest affinity to CXCR2, which was further utilized to develop an amperometric CXCL5 biosensor. Analytical parameters, such as CXCR2 receptor concentration, temperature, pH, and incubation time were optimized to obtain the high sensitivity. A dynamic range for CXCL5 detection was obtained between 0.1 and 10 ng/mL with the detection limit of 0.078 +/- 0.004 ng/mL (RSD < 4.7%). The proposed biosensor was successfully applied to detect CXCL5 in clinically relevant concentrations in human serum and colorectal cancer cells samples with high sensitivity and selectivity. Interference effect and the stability of the developed biosensor were also evaluated. Method verification was performed by comparing the results using commercially available ELISA kit for CXCL5 detection.
引用
收藏
页码:396 / 403
页数:8
相关论文
共 29 条
[1]   CCL11 (eotaxin-1): A new diagnostic serum marker for prostate cancer [J].
Agarwal, Manisha ;
He, Chang ;
Siddiqui, Javed ;
Wei, John T. ;
Macoska, Jill A. .
PROSTATE, 2013, 73 (06) :573-581
[2]  
Ashton Acton Q., 2013, COLON CANC NEW INSIG
[3]   Cancer and the chemokine network [J].
Balkwill, F .
NATURE REVIEWS CANCER, 2004, 4 (07) :540-550
[4]   Sensing and amplification of oligonucleotide-DNA interactions by means of impedance spectroscopy: a route to a Tay-Sachs sensor [J].
Bardea, A ;
Patolsky, F ;
Dagan, A ;
Willner, I .
CHEMICAL COMMUNICATIONS, 1999, (01) :21-22
[5]  
BenBaruch A, 2012, INFLAMMATORY MILIEU OF TUMORS: CYTOKINES AND CHEMOKINES THAT AFFECT TUMOR GROWTH AND METASTASIS, P1, DOI 10.2174/97816080525611120101
[6]   A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone [J].
Bersini, Simone ;
Jeon, Jessie S. ;
Dubini, Gabriele ;
Arrigoni, Chiara ;
Chung, Seok ;
Charest, Joseph L. ;
Moretti, Matteo ;
Kamm, Roger D. .
BIOMATERIALS, 2014, 35 (08) :2454-2461
[7]  
Chandra P, 2016, NANOBIOSENSORS PERSO, DOI DOI 10.1049/PBHE001E
[8]   Ultrasensitive detection of drug resistant cancer cells in biological matrixes using an amperometric nanobiosensor [J].
Chandra, Pranjal ;
Noh, Hui-Bog ;
Pallela, Ramjee ;
Shim, Yoon-Bo .
BIOSENSORS & BIOELECTRONICS, 2015, 70 :418-425
[9]   Cancer cell detection based on the interaction between an anticancer drug and cell membrane components [J].
Chandra, Pranjal ;
Noh, Hui-Bog ;
Shim, Yoon-Bo .
CHEMICAL COMMUNICATIONS, 2013, 49 (19) :1900-1902
[10]   Detection of daunomycin using phosphatidylserine and aptamer co-immobilized on Au nanoparticles deposited conducting polymer [J].
Chandra, Pranjal ;
Noh, Hui-Bog ;
Won, Mi-Sook ;
Shim, Yoon-Bo .
BIOSENSORS & BIOELECTRONICS, 2011, 26 (11) :4442-4449